Physician profile
Sarah Carson
NPI 1831738269
$1,572.91
in general payments reported to CMS, 2019-2025
16 companies · $319 in 2025
The $319 reported for 2025 was more than what a typical Gerontology (Nurse Practitioner) provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $352 · 2022: $141 · 2023: $444 · 2024: $317 · 2025: $319.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,080.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,080.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $600.46 | 2021-2025 | Repatha, Repatha |
| Scpharmaceuticals INC. | $152.81 | 2024 | |
| Edwards Lifesciences Corporation | $148.16 | 2021 | |
| Medtronic, INC. | $141.20 | 2022 | |
| Amarin Pharma, INC. | $122.55 | 2023 | |
| Boston Scientific Corporation | $101.84 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $88.79 | 2023-2024 | Brilinta, Farxiga |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $41.25 | 2025 | Lifevest |
| Kestra Medical Technology Services, INC. | $38.79 | 2024-2025 | Assure Wcd |
| E.R. Squibb & Sons, L.L.C. | $27.94 | 2023 | Eliquis |
| Abbott Laboratories | $23.75 | 2025 | Mitraclip |
| Bridgebio Pharma, INC. | $20.81 | 2025 | Attruby |
| Novartis Pharmaceuticals Corporation | $19.68 | 2025 | |
| Janssen Pharmaceuticals, INC | $17.17 | 2023 | Xarelto |
| Esperion Therapeutics, INC. | $14.07 | 2023 | Nexletol |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.64 | 2023 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Carson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.